Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Melbourne Eye Specialists
mi
from
Fitzroy,
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Melbourne Eye Specialists
mi
from
Fitzroy,
Click here to add this to my saved trials
Genetic Testing to Understand and Address Renal Disease Disparities
Genomic Medicine Pilot for Hypertension and Kidney Disease in Primary Care
Status: Enrolling
Updated:  1/16/2018
Institute for Family Health
mi
from
New York, NY
Genetic Testing to Understand and Address Renal Disease Disparities
Genomic Medicine Pilot for Hypertension and Kidney Disease in Primary Care
Status: Enrolling
Updated: 1/16/2018
Institute for Family Health
mi
from
New York, NY
Click here to add this to my saved trials
Genetic Testing to Understand and Address Renal Disease Disparities
Genomic Medicine Pilot for Hypertension and Kidney Disease in Primary Care
Status: Enrolling
Updated:  1/16/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Genetic Testing to Understand and Address Renal Disease Disparities
Genomic Medicine Pilot for Hypertension and Kidney Disease in Primary Care
Status: Enrolling
Updated: 1/16/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Baltimore VA Medical Center
mi
from
Baltimore, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Baltimore VA Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Keypoint Health System
mi
from
Baltimore, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Keypoint Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Sheppard Pratt Health System
mi
from
Baltimore, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP)
mi
from
Catonsville, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP)
mi
from
Catonsville, MD
Click here to add this to my saved trials
Impact of Renal SympAthetic DenerVation on Chronic HypErtension
Impact of Renal SympAthetic DenerVation on Chronic HypErtension
Status: Enrolling
Updated:  1/17/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Impact of Renal SympAthetic DenerVation on Chronic HypErtension
Impact of Renal SympAthetic DenerVation on Chronic HypErtension
Status: Enrolling
Updated: 1/17/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension
Status: Enrolling
Updated:  1/17/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension
Status: Enrolling
Updated: 1/17/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
Phase II, Randomized, Double-masked, Active-controlled Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Subjects With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated:  1/19/2018
Inotek Pharmaceuticals Corporation
mi
from
Lexington, MA
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
Phase II, Randomized, Double-masked, Active-controlled Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Subjects With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 1/19/2018
Inotek Pharmaceuticals Corporation
mi
from
Lexington, MA
Click here to add this to my saved trials
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 10 mg Amlodipine Besylate Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Gateway Medical Research, Inc.
mi
from
Saint Charles, MO
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 10 mg Amlodipine Besylate Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Gateway Medical Research, Inc.
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 10 mg Amlodipine Besylate Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Gateway Medical Research, Inc.
mi
from
Saint Charles, MO
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 10 mg Amlodipine Besylate Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Gateway Medical Research, Inc.
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Perindopril Erbumine Tablets 8 mg Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Perindopril Erbumine Tablets 8 mg Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Perindopril Erbumine Tablets 8 mg Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Perindopril Erbumine Tablets 8 mg Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment Bioequivalency Study of Losartan Potassium Tablets 100 mg Under Fasted Conditions
Status: Enrolling
Updated:  1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment Bioequivalency Study of Losartan Potassium Tablets 100 mg Under Fasted Conditions
Status: Enrolling
Updated: 1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment Bioequivalency Study of Losartan Potassium Tablets 100 mg Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
BioKinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment Bioequivalency Study of Losartan Potassium Tablets 100 mg Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
BioKinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan / Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan / Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan / Hydrochlorothiazide 300/25 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan / Hydrochlorothiazide 300/25 mg Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Aesthetic Eye Care Institute
mi
from
Newport Beach, CA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Aesthetic Eye Care Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Robert Noecker, M.D., M.B.A.
mi
from
Fairfield, CT
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Robert Noecker, M.D., M.B.A.
mi
from
Fairfield, CT
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Coastal Research Associates, LLC
mi
from
Roswell, GA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Coastal Research Associates, LLC
mi
from
Roswell, GA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Heart of America Eye Care, P.A.
mi
from
Shawnee Mission, KA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Heart of America Eye Care, P.A.
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Rochester Ophthalmology Group
mi
from
Rochester, NY
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Rochester Ophthalmology Group
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
The Eye Institute
mi
from
Tulsa, OK
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
The Eye Institute
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Wills Eye Hospital
mi
from
Philadelphia, PA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Wills Eye Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Univ Eye Surgeons, Maryville Ctr.
mi
from
Maryville, TN
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Univ Eye Surgeons, Maryville Ctr.
mi
from
Maryville, TN
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Texan Eye
mi
from
Austin, TX
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Texan Eye
mi
from
Austin, TX
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Comprehensive Eye Care
mi
from
Saint Louis, MO
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Comprehensive Eye Care
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women
A Comparison of B Type Natriuretic Peptide Levels and Hemodynamics Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women - A Pilot Study
Status: Enrolling
Updated:  1/26/2018
University of California, Department of OBGYN
mi
from
Orange, CA
A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women
A Comparison of B Type Natriuretic Peptide Levels and Hemodynamics Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women - A Pilot Study
Status: Enrolling
Updated: 1/26/2018
University of California, Department of OBGYN
mi
from
Orange, CA
Click here to add this to my saved trials
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
Status: Enrolling
Updated:  1/26/2018
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
Status: Enrolling
Updated: 1/26/2018
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Frailty in Children With Cardiac Disease
Frailty in Children With Cardiac Disease: A Pilot Study
Status: Enrolling
Updated:  1/27/2018
Children's Mercy Hospital
mi
from
Kansas City, MO
Frailty in Children With Cardiac Disease
Frailty in Children With Cardiac Disease: A Pilot Study
Status: Enrolling
Updated: 1/27/2018
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Chiropractic for Hypertension in Patients
Upper Cervical Manipulation for Patients With Stage 1 Hypertension
Status: Enrolling
Updated:  1/30/2018
Palmer College of Chirpractic
mi
from
Davenport, IA
Chiropractic for Hypertension in Patients
Upper Cervical Manipulation for Patients With Stage 1 Hypertension
Status: Enrolling
Updated: 1/30/2018
Palmer College of Chirpractic
mi
from
Davenport, IA
Click here to add this to my saved trials
Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products
Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products
Status: Enrolling
Updated:  1/30/2018
University of Texas at Austin
mi
from
Austin, TX
Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products
Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products
Status: Enrolling
Updated: 1/30/2018
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2
Status: Enrolling
Updated:  2/2/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2
Status: Enrolling
Updated: 2/2/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3
Status: Enrolling
Updated:  2/2/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3
Status: Enrolling
Updated: 2/2/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
REACH OUT: to Reduce High Blood Pressure in the Emergency Department
Status: Enrolling
Updated:  2/7/2018
Clinical Research Facility
mi
from
Ann Arbor, MI
REACH OUT: to Reduce High Blood Pressure in the Emergency Department
Status: Enrolling
Updated: 2/7/2018
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Vitamin D Deficiency in Patients With Hypertension
Vitamin D Deficiency, Renin Inhibitor Response, and Vitamin D Supplementation in Patients With Hypertension
Status: Enrolling
Updated:  2/9/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Vitamin D Deficiency in Patients With Hypertension
Vitamin D Deficiency, Renin Inhibitor Response, and Vitamin D Supplementation in Patients With Hypertension
Status: Enrolling
Updated: 2/9/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People
Status: Enrolling
Updated:  2/9/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People
Status: Enrolling
Updated: 2/9/2018
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
An Advanced Echocardiographic Evaluation of Nebivolol
An Advanced Echocardiographic Evaluation of Nebivolol
Status: Enrolling
Updated:  2/13/2018
University of Cincinnati
mi
from
Cincinnati, OH
An Advanced Echocardiographic Evaluation of Nebivolol
An Advanced Echocardiographic Evaluation of Nebivolol
Status: Enrolling
Updated: 2/13/2018
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Status: Enrolling
Updated:  2/13/2018
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Status: Enrolling
Updated: 2/13/2018
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase 2 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling
Updated:  2/13/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase 2 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling
Updated: 2/13/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase 2 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling
Updated:  2/13/2018
University of California, Davis Medical Center
mi
from
Sacramento, CA
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase 2 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling
Updated: 2/13/2018
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase 2 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling
Updated:  2/13/2018
University of California San Diego Medical Center
mi
from
San Diego, CA
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase 2 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Status: Enrolling
Updated: 2/13/2018
University of California San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials